MJH Life Sciences to hold back-to-school webinar

August 18, 2020
Keith A. Reynolds
Keith A. Reynolds

The free webinar will be held at 6 p.m. EDT on Aug. 26.

It’s that time of year again where traditionally parents and students would be preparing to return to school, but due to the COVID-19 coronavirus pandemic this year’s back-to-school is particularly fraught with obstacles.

MJH Life Sciences will hold a free webinar at 6 p.m. EDT on Aug. 26 to discuss some of the pressing questions facing school administrators, teachers, and parents as they seek to re-open school facilities. Some of these questions include:

  • Can children return to classrooms that assure health and wellbeing for all?
  • What factors should be considered when creating policies around masks, testing, and infection prevention in the school environment?
  • Where do children fall on the list of prospective vaccine recipients once one is available and will vaccination be mandatory?

The one-hour live webinar will feature the biggest names in pediatrics and pharmacy discussing and debating current guidance from the Centers for Disease Control and Prevention, what a safe return-to-school plan looks like, and the pros and cons of making COVID-19 vaccinations mandatory. They will also share advice on how to counsel parents through this confusing time.

Sign up for the webinar here.

Speakers will include:

  • Moderator Kathleen Kenny, PharmD, has 20+ years of clinical training and experience, Kathleen believes that well-educated patients and knowledgeable practitioners both contribute to improved health outcomes. Kenny works in retail pharmacy and in medical writing and is president and CEO of medical writing company Med Ink Exec, LLC.
  • Donna Hallas, PhD, PPCNB-BC, CPNP, PMHS, FAANP, FAAN, is a clinical professor and director of the Pediatrics NP Program at New York University Meyers College of Nursing and has present nationally and internationally on her research that focuses on improving healthcare outcomes for vulnerable children in pediatric populations. Her current research is on vaccine hesitancy and vaccine resistance in prenatal women and mothers of young children.
  • Paul Lipkin, MD, is an associate professor of pediatrics at the Kennedy Krieger Institute (KKI) and the Johns Hopkins School of Medicine, as well as KKI’s director of outpatient medical services. His clinical and research careers are focused on the early identification, evaluation, and treatment of children and adolescents with developmental disabilities like autism, learning, and attention disorders.